José Alcamí Pertejo

Carlos III Institute of Health - AIDS Immunopathogenesis Unit

c/ Monforte de Lemos 5

Madrid, Madrid 28029

Spain

SCHOLARLY PAPERS

4

DOWNLOADS
Rank 8,517

SSRN RANKINGS

Top 8,517

in Total Papers Downloads

7,918

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)

Number of pages: 38 Posted: 27 May 2021
La Paz University Hospital - Servicio de Farmacología Clínica, La Paz University Hospital - Servicio de Farmacología Clínica, Carlos III Institute of Health - Laboratorio de Serología, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), Hospital Vall d’Hebron - Servicio de Medicina Preventiva y Epidemiología, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Carlos III Institute of Health - National Centre for Microbiology, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Carlos III Institute of Health - Laboratorio de Serología, Institut de Recerca Hospital Universitari Vall d’Hebron (VHIR) - Unidad de Soporte a la Investigación Clínica, Universidad Complutense de Madrid (UCM) - Servicio de Farmacología Clínica, University Hospital 12 de Octubre, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Autonomous University of Barcelona - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, Carlos III Institute of Health - Laboratorio de Referencia en Inmunología, Carlos III Institute of Health - AIDS Immunopathogenesis Unit, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica and Independent
Downloads 7,721 (1,199)
Citation 11

Abstract:

Loading...

Immunogenic Dynamics and SARS-CoV-2 Variants Neutralization of the Heterologous ChAdOx1-S/BNT162b2 Vaccination: Secondary Analysis of the CombiVacS Study

Number of pages: 82 Posted: 25 Mar 2022
Carlos III Institute of Health - AIDS Immunopathogenesis Unit, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Hospital Vall d’Hebron - Servicio de Medicina Preventiva y Epidemiología, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, Hospital Universitario Cruces, Hospital Clínic de Barcelona, Institut de Recerca Hospital Universitari Vall d’Hebron (VHIR) - Unidad de Soporte a la Investigación Clínica, Universidad Complutense de Madrid (UCM) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health, Carlos III Institute of Health, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health - Laboratorio de Referencia en Inmunología, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, Carlos III Institute of Health - National Centre for Microbiology and Independent
Downloads 49 (547,726)

Abstract:

Loading...

Immunogenic Dynamics and SARS-CoV-2 Variants Neutralization of the Heterologous ChAdOx1-S/BNT162b2 Vaccination: Secondary Analysis of the CombiVacS Study

Number of pages: 39 Posted: 21 Mar 2022
Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), affiliation not provided to SSRN, affiliation not provided to SSRN, La Paz University Hospital - Servicio de Farmacología Clínica, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Hospital Vall d’Hebron - Servicio de Medicina Preventiva y Epidemiología, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, University of the Basque Country - Biocruces Bizkaia Health Research Institute, affiliation not provided to SSRN, Institut de Recerca Hospital Universitari Vall d’Hebron (VHIR) - Unidad de Soporte a la Investigación Clínica, Universidad Complutense de Madrid (UCM) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Icahn School of Medicine at Mount Sinai - Precision Immunology Institute, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, Carlos III Institute of Health - Laboratorio de Serología, Carlos III Institute of Health - AIDS Immunopathogenesis Unit and Independent
Downloads 38 (606,413)

Abstract:

Loading...

SARS-CoV-2, heterologous vaccination, Neutralisation, Variants, antibodies

3.

Immune Response and Reactogenicity After Immunization With a Suboptimal Two-Dose mRNA Vaccine Followed by a Full Vaccination With a Standard mRNA Vaccine Compared to a Prime-Boost Regimen of a Standard mRNA Vaccine: A Multicenter Cohort Study

Number of pages: 32 Posted: 15 Feb 2022
Universidad Complutense de Madrid (UCM) - Servicio de Farmacología Clínica, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), Carlos III Institute of Health - Laboratorio de Serología, University of the Basque Country - Biocruces Bizkaia Health Research Institute, affiliation not provided to SSRN, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health, University of the Basque Country - Biocruces Bizkaia Health Research Institute, affiliation not provided to SSRN, Hospital Clinico San Carlos, University of Barcelona - AIDS Research Group, affiliation not provided to SSRN, affiliation not provided to SSRN, Carlos III Institute of Health, Carlos III Institute of Health, Hospital Clinico San Carlos, affiliation not provided to SSRN, Carlos III Institute of Health - AIDS Immunopathogenesis Unit and Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica
Downloads 74 (441,153)

Abstract:

Loading...

COVID-19 vaccines, m-RNA, vaccines, cohort-study, experimental, vaccines, variants, neutralization, antibodies, omicron, Immunogenicity, vaccine, reactogenicity, CVnCoV vaccine, BNT162b2 vaccine

4.

Cellular and Humoral Functional Responses After BNT162b2 SARS-CoV-2 mRNA Vaccination Differ Between Naïve and COVID-19-Recovered Individuals

Number of pages: 44 Posted: 07 Jul 2021
La Paz University Hospital - The Innate Immune Response Group, La Paz University Hospital - The Innate Immune Response Group, La Paz University Hospital - The Innate Immune Response Group, La Paz University Hospital - Emergency Department and Emergent Pathology Research Group, La Paz University Hospital - The Innate Immune Response Group, La Paz University Hospital - The Innate Immune Response Group, La Paz University Hospital - The Innate Immune Response Group, La Paz University Hospital - The Innate Immune Response Group, Carlos III Institute of Health - AIDS Immunopathogenesis Unit, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), Universidad Carlos III de Madrid - AIDS Immunopathogenesis Unit, La Paz University Hospital - Emergency Department and Emergent Pathology Research Group, La Paz University Hospital - The Innate Immune Response Group, La Paz University Hospital - Emergency Department and Emergent Pathology Research Group, La Paz University Hospital - Emergency Department and Emergent Pathology Research Group, La Paz University Hospital - Emergency Department and Emergent Pathology Research Group, Eurofins-Ingenasa, Eurofins-Ingenasa, La Paz University Hospital - The Innate Immune Response Group, La Paz University Hospital - The Innate Immune Response Group, La Paz University Hospital - The Innate Immune Response Group and La Paz University Hospital - The Innate Immune Response Group
Downloads 36 (604,368)

Abstract:

Loading...

SARS-CoV-2, BNT162b2 vaccine, COVID-19-recovered, cellular responses